International Companies

Eli Lilly shares rise on positive results from Foundayo weight loss trial

By Benjamin Chiou

Date: Monday 08 Jun 2026

(Sharecast News) - Shares in Eli Lilly and Co were rising in pre-market trade on Monday after the US pharma group reported positive results from a trial of its Foundayo weight-loss drug.
The company said that Foundayo, which is the only oral GLP-1 taken without food or water restrictions, was associated...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page